Douglas Treco
2023
In 2023, Douglas Treco earned a total compensation of $5.3M as Chief Executive Officer at Inozyme Pharma.
Compensation breakdown
| Bonus | $7,500 |
|---|---|
| Non-Equity Incentive Plan | $200,000 |
| Option Awards | $4,134,601 |
| Salary | $375,000 |
| Stock Awards | $573,000 |
| Other | $9,375 |
| Total | $5,299,476 |
Treco received $4.1M in option awards, accounting for 78% of the total pay in 2023.
Treco also received $7.5K in bonus, $200K in non-equity incentive plan, $375K in salary, $573K in stock awards and $9.4K in other compensation.
Rankings
In 2023, Douglas Treco's compensation ranked 105th out of 2,918 executives tracked by ExecPay. In other words, Treco earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 105 out of 2,918 | 96th |
Division Manufacturing | 58 out of 1,608 | 96th |
Major group Chemicals And Allied Products | 35 out of 901 | 96th |
Industry group Drugs | 34 out of 864 | 96th |
Industry Pharmaceutical Preparations | 23 out of 622 | 96th |
Source: SEC filing on April 26, 2024.
Treco's colleagues
We found three more compensation records of executives who worked with Douglas Treco at Inozyme Pharma in 2023.